The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

Author(s): Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen*, Wei Zhang*

Journal Name: Current Drug Targets

Volume 21 , Issue 11 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Among the major components of green tea, epigallocatechin-3-gallate (EGCG) is the most effective for its anti-cancer characteristics. The bulk of studies provide the mechanisms of suppressive function of EGCG are involved in alteration of cancer cell cycle, development, and apoptosis through activation/inhibition of several signal pathways.

Another mechanism that explains the multiple effects exerted by EGCG in cancer is the epigenetic change by DNA methylation or methyltransferases, histone acetylation or deacetylases, and no coding RNAs (micoRNAs). Furthermore, decontrolled expression of miRNA transcription has been tested to be directly regulated by oncogenic and tumor-suppressor transcription factors. Recently, several proteins have been identified as miRNA direct interactors by EGCG. However, the mechanisms explaining the action of miRNA being modulated by EGCG have not been completely understood yet. This review summarizes the state of epigenetic change being modulated by EGCG in a variety of cancers and oncogenic and tumor-suppressor transcription factors.

Keywords: Epigallocatechin-gallate (EGCG), micoRNA, cancer, epigenetic regulators, methyltransferases, miRNA.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [1099 - 1104]
Pages: 6
DOI: 10.2174/1389450121666200504080112
Price: $65

Article Metrics

PDF: 36